ODM-105 0.3 mg/ml oral solution, ODM-105 0.05 mg/ml oral solution, ODM-105 placebo oral solution clinical trials

Efficacy and tolerability of tasipimidine after 3 repeated bed-time doses in patients with insomnia disorder with a 4-week extension part

This study is testing a new liquid medicine, tasipimidine, to see if it helps people with insomnia sleep better. Researchers are checking how well it works and if it has any side effects, particularly how it affects waking up during the night and how long it takes to fall asleep.